Literature DB >> 6340906

Relative hyperglucagonemia in L-asparaginase-and prednisone-induced glucose intolerance in management of acute lymphocytic leukemia.

G R Turner, J F Marks, G R Buchanan.   

Abstract

Ten children with acute lymphocytic leukemia developed transient diabetes mellitus during treatment with L-asparaginase and prednisone. Serum glucose, plasma insulin, and plasma glucagon levels were measured when the patients were hyperglycemic. Six of the children were restudied several months later when there were no clinical or laboratory signs of glucose intolerance. Hyperglycemia induced by L-asparaginase and prednisone was associated with depression of plasma insulin and, despite the inhibiting action of L-asparaginase on protein synthesis, a corresponding elevation of plasma glucagon. Thus patients with diabetes mellitus induced by L-asparaginase and prednisone have relative hyperglucagonemia similar to other patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6340906     DOI: 10.1177/000992288302200507

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  1 in total

1.  Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.

Authors:  Hideki Yoshida; Toshihiko Imamura; Akiko M Saito; Yoshihiro Takahashi; So-ichi Suenobu; Daiichiro Hasegawa; Takao Deguchi; Yoshiko Hashii; Hirohide Kawasaki; Mikiya Endo; Hiroki Hori; Nobuhiro Suzuki; Yoshiyuki Kosaka; Koji Kato; Keiko Yumura-Yagi; Junichi Hara; Megumi Oda; Atsushi Sato; Keizo Horibe
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.